Novavax (NVAX) option implied volatility into FDA granted EUA for COVID-19 vaccine
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) 30-day option implied volatility is at 145; compared to its 52-week range of 64 to 167 into FDA granted EUA for COVID-19 vaccine.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
- Burlington Stores (BURL) 3700 contracts of September 25 weekly 305 puts trade
- Academy Sports and Outdoor (ASO) 3600 contracts of August 52 calls trade
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
